Requires certain pharmacists or pharmacies to provide the amount of the national average drug acquisition cost for a generic drug on the written materials provided to an individual at the point of sale of the generic drug.
- Chamber
- Senate
- Introduced
- Jan 5, 2026
- Last action
- Jan 28, 2026 — First reading: referred to Committee on Public Health
- Session
- 2026
- Momentum
- 66 · High